Asia-Pacific Immunoassay-Gamma Counters Market Analysis, Demand & Growth Forecast

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTES FIVE FORCES

5 REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS

5.1 U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS

5.2 EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

5.3 JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

5.4 CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASE IN PREVALENCE OF CHRONIC DISEASES

6.1.2 PRODUCT APPROVAL

6.1.3 INCREASE IN ADOPTION OF NUCLEAR MEDICINE

6.1.4 NOVELTY IN DIAGNOSIS PROCEDURES

6.1.5 UPGRADING GAMMA TECHNOLOGY

6.2 RESTRAINTS

6.2.1 HIGH COST OF GAMMA COUNTER

6.2.2 RISK OF GAMMA RADIATION

6.2.3 STRINGENT REGULATION OF CLINICAL USE OF GAMMA COUNTER

6.2.4 PRODUCT RECALL

6.3 OPPORTUNITIES

6.3.1 GROWING RESEARCH AND DEVELOPMENT EXPENDITURE

6.3.2 INCREASE IN HEALTHCARE EXPENDITURE

6.3.3 RISE IN PATIENTS AWARENESS TOWARDS CHRONIC DISEASE TREATMENT

6.4 CHALLENGES

6.4.1 CHALLENGES IN USING GAMMA COUNTER

6.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

7 IMPACT OF COVID-19 ON ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET

7.1 IMPACT ON THE PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY

7.4 STRATEGIC INITIATIVES BY MANUFACTURERS

7.5 CONCLUSION

8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 AUTOMATED

8.2.1 RADIOIMMUNOASSAYS

8.2.1.1 RIA

8.2.1.2 IRMA

8.2.2 NUCLEAR MEDICINE ASSAYS

8.2.2.1 GFR (Glomerular FILTRATION RATE)

8.2.2.2 Gamma glutamyl transferase (ggt)

8.2.2.3 red cell mass and plasma volume test

8.2.2.4 THE SCHILLING TEST

8.2.2.5 others

8.2.3 OTHERS

8.3 MANUAL/SEMI-AUTOMATED

8.3.1 RADIOIMMUNOASSAYS

8.3.1.1 RIA

8.3.1.2 IRMA

8.3.2 NUCLEAR MEDICINE ASSAYS

8.3.2.1 GFR (Glomerular FILTRATION RATE)

8.3.2.2 Gamma glutamyl transferase (ggt)

8.3.2.3 red cell mass and plasma volume test

8.3.2.4 THE SCHILLING TEST

8.3.2.5 others

8.3.3 OTHERS

9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL

9.1 OVERVIEW

9.2 MULTI-WELL

9.3 SINGLE-WELL

10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 RADIO IMMUNOASSAYS

10.2.1 RIA

10.2.2 IRMA

10.3 NUCLEAR MEDICINE ASSAY

10.3.1 GFR (GLOMERULAR FILTRATION RATE)

10.3.2 GAMMA-GLUTAMYL TRANSFERASE

10.3.3 RED CELL MASS AND PLASMA VOLUME TEST

10.3.4 THE SCHILLING TEST

10.3.5 OTHERS

10.4 OTHERS

11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION

11.1 OVERVIEW

11.2 CANCER BIOMARKERS

11.2.1 CARBOHYDRATE ANTIGEN 125 (CA125)

11.2.2 CARBOHYDRATE ANTIGEN 19-9

11.2.3 CARCINO EMBRYONIC ANTIGEN

11.2.4 ALPHA-FETOPROTEIN

11.2.5 OTHERS

11.3 INFECTIOUS DISEASES

11.4 THERAPEUTIC DRUG MONITORING

11.5 ENDOCRINE HORMONES

11.6 ALLERGY

11.7 NEONATAL SCREENING

11.8 CARDIAC MARKERS

11.9 AUTOIMMUNE DISEASE

11.1 OTHERS

12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE

12.1 OVERVIEW

12.2 OUTRIGHT PURCHASE

12.3 RENTAL PURCHASE

13 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 THIRD PARTY DISTRIBUTORS

14 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOSPITALS

14.3 LABORATORY

14.4 BLOOD BANKS

14.5 RESEARCH AND ACADEMIC INSTITUTES

14.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

14.7 OTHERS

15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY GEOGRAPHY

15.1 ASIA-PACIFIC

15.1.1 JAPAN

15.1.2 SOUTH KOREA

15.1.3 CHINA

15.1.4 AUSTRALIA

15.1.5 INDIA

15.1.6 SINGAPORE

15.1.7 THAILAND

15.1.8 MALAYSIA

15.1.9 INDONESIA

15.1.10 PHILIPPINES

15.1.11 REST OF ASIA-PACIFIC

16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 PERKINELMER INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 BRETHOLD TECHNOLOGIES GMBH & CO.KG

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 LABLOGIC SYSTEMS LTD.

18.3.1 COMPANY SNAPSHOT

18.3.2 COMPANY SHARE ANALYSIS

18.3.3 PRODUCT PORTFOLIO

18.3.4 RECENT DEVELOPMENT

18.4 SHIN JIN MEDICS INC.

18.4.1 COMPANY SNAPSHOT

18.4.2 COMPANY SHARE ANALYSIS

18.4.3 PRODUCT PORTFOLIO

18.4.4 RECENT DEVELOPMENTS

18.5 HIDEX OY

18.5.1 COMPANY SNAPSHOT

18.5.2 COMPANY SHARE ANALYSIS

18.5.3 PRODUCT PORTFOLIO

18.5.4 RECENT DEVELOPMENTS

18.6 LABORATORY TECHNOLOGIES. INC.

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 ENERSYS, CO.LTD.

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 MIRION TECHNOLOGIES (CAPINTEC),INC.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

TABLE 1 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 4 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 5 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 6 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 7 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 8 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 9 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 10 ASIA-PACIFIC RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 11 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 13 ASIA-PACIFIC MULTI-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 14 ASIA-PACIFIC SINGLE-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 16 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 17 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 18 ASIA-PACIFIC NUCLEAR MEDICINE ASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 19 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 20 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 22 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 23 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 24 ASIA-PACIFIC INFECTIOUS DISEASES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 25 ASIA-PACIFIC THERAPEUTIC DRUG MONITORING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 26 ASIA-PACIFIC ENDOCRINE HORMONES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 27 ASIA-PACIFIC ALLERGY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 28 ASIA-PACIFIC NEONATAL SCREENING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 29 ASIA-PACIFIC CARDIAC MAKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 30 ASIA-PACIFIC AUTO IMMUNE DISEASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 31 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 33 ASIA-PACIFIC OUTRIGHT PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC RENTAL PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC DIRECT TENDER IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC HOSPITALS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC LABORATORY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC BLOOD BANKS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 20152028 (USD MILLION)

TABLE 42 ASIA-PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 44 OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY COUNTRY, 2015-2028 (USD MILLION)

TABLE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 47 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 48 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 49 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 50 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 51 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 52 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 53 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 54 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 55 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 56 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 57 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 58 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 59 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 60 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 61 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 62 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 63 JAPAN AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 64 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 65 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 66 JAPAN MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 67 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 68 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 69 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 70 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 71 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 72 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 73 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 74 JAPAN CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 75 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 76 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 77 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 78 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 79 SOUTH KOREA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 80 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 81 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 82 SOUTH KOREA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 83 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 84 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 85 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 86 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 87 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 88 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 89 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 90 SOUTH KOREA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 91 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 92 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 93 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 94 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 95 CHINA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 96 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 97 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 98 CHINA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 99 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 100 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 101 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 102 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 103 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 104 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 105 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 106 CHINA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 107 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 108 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 109 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 110 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 111 AUSTRALIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 112 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 113 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 114 AUSTRALIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 115 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 116 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 117 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 118 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 119 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 120 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 121 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 122 AUSTRALIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 123 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 124 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 125 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 126 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 127 INDIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 128 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 129 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 130 INDIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 131 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 132 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 133 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 134 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 135 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 136 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 137 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 138 INDIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 139 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 140 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 141 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 142 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 143 SINGAPORE AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 144 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 145 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 146 SINGAPORE MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 147 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 148 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 149 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 150 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 151 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 152 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 153 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 154 SINGAPORE CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 155 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 156 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 157 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 158 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 159 THAILAND AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 160 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 161 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 162 THAILAND MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 163 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 164 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 165 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 166 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 167 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 168 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 169 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 170 THAILAND CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 171 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 172 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 173 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 174 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 175 MALAYSIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 176 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 177 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 178 MALAYSIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 179 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 180 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 181 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 182 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 183 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 184 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 185 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 186 MALAYSIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 187 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 188 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 189 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 190 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 191 INDONESIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 192 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 193 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 194 INDONESIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 195 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 196 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 197 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 198 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 199 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 200 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 201 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 202 INDONESIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 203 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 204 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 205 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 206 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 207 PHILIPPINES AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 208 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 209 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 210 PHILIPPINES MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 211 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 212 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 213 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 214 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 215 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 216 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 217 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 218 PHILIPPINES CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 219 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 220 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 221 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 222 REST OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

List of Figure

FIGURE 1 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION

FIGURE 12 INCREASE IN PREVALENCE OF CHRONIC DISEASES AND GROWING USE OF NUCLEAR MEDICINE IS EXPECTED TO DRIVE THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 AUTOMATED IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET

FIGURE 15 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS

FIGURE 16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2020

FIGURE 17 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 18 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 19 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2020

FIGURE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2021-2028 (USD MILLION)

FIGURE 22 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, CAGR (2021-2028)

FIGURE 23 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2020

FIGURE 25 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 26 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, CAGR (2021-2028)

FIGURE 27 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, 2020

FIGURE 29 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY DISEASE CONDITION, 2021-2028 (USD MILLION)

FIGURE 30 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, CAGR (2021-2028)

FIGURE 31 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2020

FIGURE 33 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2021-2028 (USD MILLION)

FIGURE 34 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, CAGR (2021-2028)

FIGURE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2020

FIGURE 37 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 39 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2020

FIGURE 41 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2021-2028 (USD MILLION)

FIGURE 42 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, CAGR (2021-2028)

FIGURE 43 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SNAPSHOT (2020)

FIGURE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020)

FIGURE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2021 &2028)

FIGURE 47 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 48 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY PRODUCT TYPE (2021-2028)

FIGURE 49 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY SHARE 2020 (%)

Frequently Asked Questions

At what growth rate will the market be projected to grow during the forecast period of 2021 to 2028?

The Asia-Pacific Immunoassay-Gamma Counters Market is projected to grow at a CAGR of 6.9% during the forecast period by 2028.

What will be the market value in the future?

The future market value of the Asia-Pacific Immunoassay-Gamma Counters Market is expected to reach USD 23.45 million by 2028.

Who are the major players operating in the market?

The major players in the Asia-Pacific Immunoassay-Gamma Counters Market are Hidex Oy, Perkin Elmer Inc, Berthold Technologies GmbH & Co. KG, ENERSYS Co. Ltd, Shinjin Medics Inc, LabLogic Systems Ltd, among others.

Which countries data are covered in the report?

The countries covered in the Asia-Pacific Immunoassay-Gamma Counters Market are Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.